DCL Learning Series

Content plays a critical role in the pharma lifecycle. While industry standards support component-based content and facilitate content reuse, they're just a starting place. For maximum benefit, you must develop a content strategy that builds on guidelines and serves your organization’s unique needs.

It was the largest conversion ever to S1000D: hundreds of thousands of OEM manual pages for a USAF aircraft. Analysis and QA required the right balance between automation and manual review. This case study presents the software and processes that were customized for this massive independent review.

Content strategists discuss challenges specific to societies & associations. They provide approaches to implement or update your content strategy toolset that allow for new opportunities in content efficiencies, content quality, improved member engagement, and monetization—without breaking the bank.

Even minor content updates send writers scurrying to find and fix every instance of pasted content across a large content library, causing content production costs to rise and content delivery to be delayed, and exposing the organization to regulatory risk. Fortunately, there is a better way.

This webinar will explore how different people in an organization can create and deliver personalized content using DITA. Real-world examples will let attendees recognize the power that DITA enables as we cover its key features like topics, maps and conditional processing to create tailored content.

Improving web and content accessibility is more achievable and affordable than ever before thanks to advanced technical systems and content markup. Publishers can move beyond the view of compliance as a requirement to a place where accessibility is a standard part of the publishing workflow.

Sponsors use many external vendors including CROs and multiple clinical sites during clinical trials. The documents and content that sponsors receive back may not be as usable as they could be. How do we put concepts in place that enable us to have a more consistent level of quality in documents?

Strategic pharma content reuse practices maintain consistency and accuracy for critical information. They also have bottom-line business benefits including streamlined workflows and reduced translation costs. We’ll show an analysis that uses AI and NLP to identify redundant content in a collection.

Content interchange: how the new format helps with indexing and searching and supports improved discoverability of AWWA’s content.

This is the first webinar in a series of informational and interactive presentations for the life sciences industry. This collaborative webinar is put together from three leading technology companies---Data Conversion Laboratory, Court Square Group, and Jana Life Sciences. Each organization highlights an aspect of technology critical to improving how the biomedical and pharma industries can increase business performance while also securing intellectual property.